The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, has successfully a raised a sum of $9.3 million investment to...
Alkermes has officially published the results from a new survey, which was designed to understand utilization of and experiences with treatment among 300 adults...
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications,...
Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, has officially raised a...
Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, is officially set to present 17 groundbreaking studies at Digestive Disease Week (DDW)...
